In vitro and in vivo human metabolism and pharmacokinetics of S‐ and R‐praziquantel
Abstract Racemic praziquantel (PZQ) is the drug of choice for the treatment of schistosomiasis. R‐Praziquantel (R‐PZQ) has been shown as the therapeutic form, whereas S‐PZQ is less efficacious and responsible for the bitter taste of the tablet. This study aimed at investigating the metabolism of R‐...
Saved in:
Main Authors: | Nyasha Nicole Kapungu (Author), Xueqing Li (Author), Charles Nhachi (Author), Collen Masimirembwa (Author), Roslyn Stella Thelingwani (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2020-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinically relevant enantiomer specific R‐ and S‐praziquantel pharmacokinetic drug‐drug interactions with efavirenz and ritonavir
by: Chenai Sheilla Mutiti, et al.
Published: (2021) -
In vitro/vivo assessment of praziquantel nanocrystals: Formulation, characterization, and pharmacokinetics in beagle dogs
by: Ruyi Yang, et al.
Published: (2019) -
Preparation and In Vitro/In Vivo Evaluation of Orally Disintegrating/Modified-Release Praziquantel Tablets
by: Xuemei Wen, et al.
Published: (2021) -
Drug metabolism and pharmacokinetics of praziquantel: A review of variable drug exposure during schistosomiasis treatment in human hosts and experimental models.
by: Grace Zdesenko, et al.
Published: (2020) -
Potent human uric acid transporter 1 inhibitors: in vitro and in vivo metabolism and pharmacokinetic studies
by: Wempe MF, et al.
Published: (2012)